News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current TDSGF market cap is 8.79M. The company's latest EPS is CAD -0.0395 and P/E is -4.56.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.05M | -1.31M | -1.26M | -2.11M | -2.82M |
| Net Income | -1.07M | -1.24M | -1.07M | -2.11M | -2.82M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 262k | 1.17M | 3.84M | 2.83M | 2.93M |
| Total Liabilities | 1.31M | 393k | 154k | 230k | 313k |
| Total Equity | -1.05M | 775k | 3.69M | 2.6M | 2.61M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -328k | -1.12M | -1.11M | -1.8M | -2.63M |
| Investing | N/A | -8k | -9k | -25k | -69k |
| Financing | 280k | 2.03M | 3.83M | 876k | 2.68M |
| Market Cap | 8.79M |
| Price to Earnings Ratio | -4.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.8 |
| Price to Book Ratio | 4.91 |
| Dividend Yield | - |
| Shares Outstanding | 71.31M |
| Average Volume (1 week) | 34.93k |
| Average Volume (1 Month) | 38.86k |
| 52 Week Change | -17.53% |
| 52 Week High | 0.24 |
| 52 Week Low | 0.0761 |
| Spread (Intraday) | 0.12 (61.95%) |
| Company Name | Telo Genomics Corporation (QB) |
| Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
| Website | https://www.telodx.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
